Skip to main content

WATSON 835 3.75 Pill - blue five-sided

Pill with imprint WATSON 835 3.75 is Blue, Five-sided and has been identified as Clorazepate Dipotassium 3.75 mg. It is supplied by Watson Laboratories, Inc.

Clorazepate is used in the treatment of Anxiety; Alcohol Withdrawal; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 3.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 835 3.75

Clorazepate dipotassium 3.75 mg WATSON 835 3.75 Front
Clorazepate dipotassium 3.75 mg WATSON 835 3.75 Back
Clorazepate dipotassium 3.75 mg WATSON 835 3.75

Clorazepate Dipotassium

WATSON 835 3.75
3.75 mg
Prescription only
Drug Class
Pregnancy Category
N - Not classified
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
52544-0835 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.